Evaluation of the Effect of Itraconazole, Quinidine and Rifampicin on the Single-Dose Pharmacokinetics of ZED1227
This research is looking at how a potential new medicine, called ZED1227, behaves in the body when healthy people take it at the same time as other common medicines. The other medicines are itraconazole (often used for fungal infections), quinidine (sometimes used for heart rhythm problems), and rifampicin (an antibiotic). The main goal is to understand if these other medicines change how much ZED1227 gets into your blood, how quickly your body gets rid of it, and if it stays in your body for longer or shorter periods. This helps us ensure ZED1227 can be used safely and effectively with other treatments in the future. This is an early-stage study, meaning it's one of the first times this new medicine is being tested in people.
At a glance
What is this study about?
This study is designed to understand how a new investigational medicine, called ZED1227, works inside the human body. Specifically, we want to see if taking ZED1227 alongside three other commonly used medications – itraconazole, quinidine, or rifampicin – changes how ZED1227 is absorbed, processed, and removed by your body. Think of it like cooking: sometimes adding one ingredient can change how another ingredient tastes or cooks. We need to know if these other medicines act like extra ingredients that change how ZED1227 behaves.
Understanding these interactions is really important for patient safety. If one medicine affects how another works, it could change how effective the new medicine is, or it could lead to unexpected side effects. By studying these interactions early on, researchers can figure out the best and safest ways for ZED1227 to be used if it ever becomes a widely available treatment.
This type of study is called a 'Phase I' human pharmacology trial. This usually means it's one of the very first studies of a new medicine in people, and it's often done in healthy volunteers. The focus is on learning about the medicine's basic journey through the body rather than treating a specific illness. This information is crucial for developing safe and effective new treatments in the future.
Key takeaways
- Tests how a new medicine works in the body.
- Investigates interactions with common medications.
- Aims to ensure future safe use of ZED1227.
- Involves healthy adult volunteers, both men and women.
- Requires multiple visits and close medical monitoring.
- Crucial for developing new medicines.
Who may be eligible?
This study is looking for healthy adult volunteers to take part. You must be at least 18 years old – there is no upper age limit, meaning older adults can also participate.
Both men and women are welcome to join this study. You won't be eligible if you have any existing medical conditions or are taking long-term medication that might interfere with the study drugs. The research team will carefully check your health to make sure it's safe for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Am I at least 18 years old?
- Do I consider myself to be in good health?
- Am I happy to stop taking any regular medications for the study period?
- Am I available for required clinic visits and potential overnight stays?
- Am I comfortable with giving blood samples regularly?
What does participation involve?
If you join this study, you will be given the new medicine ZED1227, along with either itraconazole, quinidine, or rifampicin, or sometimes just ZED1227 on its own. You'll likely need to stay at a special clinic for certain periods, where doctors and nurses can closely monitor you. This will involve regular blood tests to check the levels of the medicines in your body, and possibly other tests like heart rhythm checks (ECGs).
Taking part will involve multiple visits over a period of time, including overnight stays for some parts of the study. You'll have follow-up appointments after you've finished taking the medicines to make sure you're well. The research team will provide a detailed schedule, but expect a commitment of several weeks from start to finish, including any follow-up checks.
Potential risks and benefits
Locations (1)
- —UnverifiedPortugal
Common questions
What does 'pharmacokinetics' mean?
It's a fancy word for how medicines move through your body. It looks at how much of the medicine gets into your blood, how long it stays there, and how your body gets rid of it.
Can I still take my regular medicines during the study?
Generally no, as other medicines can affect the results. The study team will review all your current medications before you can join to ensure it's safe and won't interfere.
Will I get paid for taking part?
Many clinical studies offer some payment and cover travel expenses for your time and inconvenience. The study team will explain this to you.
Who is running this study?
This study is sponsored by a pharmaceutical company, but it's carried out by medical professionals and researchers to ensure safety and ethical standards are met.
Is ZED1227 already available as a medicine?
No, ZED1227 is an investigational medicine, meaning it's new and still being tested. It's not available for general use outside of clinical trials.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.